Receptor-Mediated Drug Delivery Systems Targeting to Glioma
about
A Novel Magnetic Actuation Scheme to Disaggregate Nanoparticles and Enhance Passage across the Blood-Brain Barrier.VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein.Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
P2860
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
@en
Receptor-Mediated Drug Delivery Systems Targeting to Glioma.
@nl
type
label
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
@en
Receptor-Mediated Drug Delivery Systems Targeting to Glioma.
@nl
prefLabel
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
@en
Receptor-Mediated Drug Delivery Systems Targeting to Glioma.
@nl
P2093
P2860
P356
P1433
P1476
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
@en
P2093
Chengyi Li
Rongqin Huang
Shanshan Wang
P2860
P356
10.3390/NANO6010003
P577
2015-12-28T00:00:00Z